1. Home
  2. XOMA vs BYON Comparison

XOMA vs BYON Comparison

Compare XOMA & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • BYON
  • Stock Information
  • Founded
  • XOMA 1981
  • BYON 1997
  • Country
  • XOMA United States
  • BYON United States
  • Employees
  • XOMA N/A
  • BYON N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • BYON Catalog/Specialty Distribution
  • Sector
  • XOMA Health Care
  • BYON Consumer Discretionary
  • Exchange
  • XOMA Nasdaq
  • BYON Nasdaq
  • Market Cap
  • XOMA 330.2M
  • BYON 556.8M
  • IPO Year
  • XOMA N/A
  • BYON N/A
  • Fundamental
  • Price
  • XOMA $32.47
  • BYON $9.44
  • Analyst Decision
  • XOMA Strong Buy
  • BYON Hold
  • Analyst Count
  • XOMA 2
  • BYON 8
  • Target Price
  • XOMA $69.50
  • BYON $10.33
  • AVG Volume (30 Days)
  • XOMA 56.1K
  • BYON 2.6M
  • Earning Date
  • XOMA 08-13-2025
  • BYON 10-23-2025
  • Dividend Yield
  • XOMA N/A
  • BYON N/A
  • EPS Growth
  • XOMA N/A
  • BYON N/A
  • EPS
  • XOMA N/A
  • BYON N/A
  • Revenue
  • XOMA $44,952,000.00
  • BYON $1,128,578,000.00
  • Revenue This Year
  • XOMA $82.30
  • BYON N/A
  • Revenue Next Year
  • XOMA $12.59
  • BYON $11.56
  • P/E Ratio
  • XOMA N/A
  • BYON N/A
  • Revenue Growth
  • XOMA 194.98
  • BYON N/A
  • 52 Week Low
  • XOMA $18.35
  • BYON $3.54
  • 52 Week High
  • XOMA $35.23
  • BYON $12.24
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 61.79
  • BYON 55.14
  • Support Level
  • XOMA $32.60
  • BYON $9.11
  • Resistance Level
  • XOMA $34.60
  • BYON $9.89
  • Average True Range (ATR)
  • XOMA 1.82
  • BYON 0.60
  • MACD
  • XOMA 0.09
  • BYON -0.00
  • Stochastic Oscillator
  • XOMA 66.75
  • BYON 72.04

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad number of products, including furniture, decor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: